CurePSP

Curepsp serves as a catalyst for developing new treatments and ultimately a cure for progressive supranuclear palsy (psp) and corticobasal degeneration (cbd), both of which are primary tauopathies. The scientific research and projects supported by Curepsp not only focus on these conditions but also benefit broader scientific priorities related to other neurodegenerative diseases, including alzheimer's, pick's disease, argyrophilic grain disease, chronic traumatic encephalopathy, and certain types of familial frontotemporal dementia. This broad impact underscores the significance of Curepsp's contributions to the field of neurological research. Continued on schedule o.curepsp's funding and partnerships are strategically focused on advancing research in several key areas: (a) understanding the causes and risk factors of neurodegeneration, (b) discovering and validating biomarkers and clinical tests to enhance diagnosis and facilitate more effective clinical trials, (c) identifying genetic variants linked to these diseases, (d) developing therapies that could prevent, halt, or reverse the brain damage caused by the pathological accumulation of proteins, and (e) assisting pharmaceutical companies and research institutions in recruiting participants for clinical trials and promoting these trials. Additionally, Curepsp collaborates with leading institutions like the mayo clinic's brain bank in jacksonville, Florida, to supply essential brain tissue samples to researchers worldwide, thereby expanding access to these crucial biological resources. Curepsp's partnerships are designed to fast-track shared objectives. In this effort, Curepsp works closely with and co-invests in programs and research alongside prominent nonprofit organizations and foundations, such as the alzheimer's association, the michael j. Fox foundation, the parkinson's foundation, and the rainwater charitable foundation, as well as patient-led organizations like mission msa in the united states and the psp association in the united kingdom.

Curepsp publishes a library of printed and online educational materials for families, patients, physicians, and other healthcare professionals. These materials are developed in collaboration with Curepsp centers of care, a network of hospitals and best-in-class academic centers specializing in treating patients with psp, cbd, and msa. Curepsp sponsors educational conferences in collaboration with leading institutions to increase knowledge and support people living with these fatal diseases. The objective is to promote education, earlier and more accurate diagnosis and better patient care. Several dozen volunteer events annually, supported by Curepsp, further educate, and empower our community to prepare for their care needs.continued on schedule o.curepsp uses several social media platforms to communicate with its constituents, maintains an online patient and caregiver forum, and produces national webinars, online support groups, and online presentations from clinicians and researchers. The Curepsp quality of life respite grant, supported by the cherie levien quality of life fund, offers financial assistance to make professional in-home care more affordable and accessible for families in need.as part of its educational outreach, Curepsp hosts "ask the experts" interactive webinars, where researchers and healthcare professionals share their insights, advice, and research findings with patients and caregivers. Additionally, Curepsp conducts an annual online "wellness workshop" to educate attendees on managing disease burden and the stresses associated with caregiving for these incurable disorders. Supporting over 50 virtual and in-person support groups, Curepsp leverages its network of more than 270 volunteers globally to provide comprehensive online, telephone, and face-to-face support.curepsp also spearheads the Curepsp center of care program, a collaborative alliance that fosters a network of medical and research centers across the united states and canada. This program aims to connect individuals diagnosed with psp (progressive supranuclear palsy), cbd (corticobasal degeneration), and msa (multiple system atrophy) with top-tier care. The mission of the Curepsp centers of care is multifaceted, focusing on enhancing access to accurate and early diagnoses, providing state-of-the-art clinical care, offering comprehensive support, serving as regional leaders, raising awareness of these diseases, optimizing care standards, and fostering multi-center research initiatives. These centers are often selected as sites for clinical trials, where Curepsp's strategic partnerships help pharmaceutical companies identify the best locations for trials and enhance trial quality. Additionally, the collaborative approaches to resources, education, and support (cares) grant program, launched in 2022, aims to foster partnerships within the center network to address the unmet care needs of the Curepsp community.

The prevalence of progressive supranuclear palsy (psp) is on par with that of als (amyotrophic lateral sclerosis), yet psp, along with corticobasal degeneration (cbd) and multiple system atrophy (msa), remains significantly underrecognized compared to als. Curepsp is dedicated to raising awareness for these conditions and supporting the patients, families, and caregivers affected by them, empowering them to advocate effectively for their needs. The organization is committed to enhancing quality of life and patient outcomes by building a resilient and supportive community that boosts awareness. Continued on schedule o.curepsp pursues these goals through volunteer development programs, professional education, and by distributing educational resources both online and in print for the public and healthcare professionals. Additionally, it actively shares vital information through social media and online newsletters and encourages community involvement in legislative advocacy efforts aimed at improving quality of life for those impacted. With the aid of volunteers, Curepsp is also advancing its public policy agenda, focusing on increasing awareness and support for psp, cbd, and msa.